Living with ulcerative colitis (UC) means managing symptoms like bloating and cramps, but theres another serious complication to be aware of: a higher risk of blood clots. In fact, research shows that ...

In patients with active ulcerative colitis (UC) who initiated vedolizumab, loss of vedolizumab in stool samples was noted in more than 75% of patients, with higher rates of drug loss seen in those ...

Omvoh is a biologic medicine used to treat moderate to severe ulcerative colitis. Ulcerative colitis is an inflammatory bowel disease that causes inflammation in parts of the digestive tract. Common ...

Risk of venous thromboembolism and cardiovascular events in ulcerative colitis (UC) patients on advanced therapies were lower with vedolizumab (Entyvio) compared with TNF inhibitors in a real-world ...

Obefazimod 50 mg once daily demonstrated efficacy in patients with moderate to severely active ulcerative colitis (UC), with 52.5% achieved clinical remission at 96 weeks of open-label maintenance ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

Regular stool tests already used in NHS care, combined with dietary information, could help identify people with inflammatory bowel disease (IBD) at higher risk of relapse, a major study appearing in ...

Picture this common clinical scenario: A patient has chronic diarrhea, abdominal pain, and weight loss. Blood and stool tests point to inflammatory bowel disease (IBD). But which one -- Crohn's ...

Ulcerative colitis often develops in people aged 15-30 or 50-70. Exercise can reduce inflammation and strengthen the intestinal lining. A fecal occult blood test is a noninvasive test that can help ...

Millions of people worldwide suffer from ulcerative colitis, a type of inflammatory bowel disease that causes ulcers in the colon. Its symptoms include abdominal pain, bleeding with stools, and fever, ...